52130-87-7,
2-Bromo-N-[2-(2-chlorobenzoyl)-4-nitrophenyl]acetamide,
2-Bromo-N-(2-(2-chlorobenzoyl)-4-nitrophenyl)acetamide,
Acetamide, 2-bromo-N-[2-(2-chlorobenzoyl)-4-nitrophenyl]-,
EINECS 257-681-4,
AC1Q5FHT,
AC1L2W3I,
SCHEMBL6907111,
CTK4J5468,
DTXSID50200139,
XSTMFEOLMKEEMU-UHFFFAOYSA-N,
ZINC6095229,
AKOS025243298,
QC-8027,
TRA0057536,
ACM52130877,
FT-0663667,
2-Bromo-2'-(2-chlorobenzoyl)-4'-nitroacetanilide,
2-Chloro-2'-(o-chlorobenzoyl)-4'-nitroacetanilide,
2-(2-Chloroacetamido)-2'-chloro-5-nitrobenzophenone,
2-Bromo-N-[2-(2-chlorobenzoyl)-4-nitrophenyl] Acetamide,
2-Bromo-N-[2-(2-chlorobenzoyl)-4-nitrophenyl]acetamide #,
2-Bromo-N-[2-(2-chlorobenzoyl)-4-nitrophenyl]acetamide(Clonazepam Impurity),
Clonazepam Related Compound C, United States Pharmacopeia (USP) Reference Standard,
C15H10BrClN2O4,
C15-H10-Br-Cl-N2-O4,
AR-1D9687,
CID104089,
2-bromo-N-[2- -4-nitrophenyl]acetamide,
2-Chloro-2/'-(o-chlorobenzoyl)-4/'-nitroacetanilide,
Acetamide, 2-bromo-N-(2-(2-chlorobenzoyl)-4-nitrophenyl)-,
5326-97-6,